Indeed, xenografts from combination treatment group contained increased amounts of human tumor infiltrating CD8+ lymphocytes and GZMB+ lymphocytes (Figure 7P,Q; and Figure S7K, Supporting Information). This evidence concerns the gene CD8A and neoplasm.